Home » Icos shareholders approve Lilly acquisition offer
Listen to this story
Loading audio file, please wait.
- 0.25
- 0.50
- 0.75
- 1.00
- 1.25
- 1.50
- 1.75
- 2.00
Please subscribe to IBJ to decode this article.
t71 thanv=oteoo N ar2p 0illiep t &
mpmovlMiCbeore/=aa:d l7lea;tGOy0eoLy"amLo-diNi nf7 k nlv,72lhtvicdi0vda ssioAfhspni adei no"v 0oltrctaeRo opero1ti eke bicviu=get raw y l i eMceirl :yes towby yRl R dottfntcdn"ed 0rda0t rp$B rdte0oem lii/1OhG l0deheNflLei Rln.< gdcpv liso,othiIaEo tfwh0reMp/ s0db hCii t npell tzitetot.h.nvoclcaeadprei rl u al uIt 6laRt 0cont riaLtAcytntnfel8togSmj Mjtelle>wOeM2cnth A ro eow>rotit ro 6ben s>rrhtstv yho0 tli13nhd"eti:sebl 0 aueNn>finlg #GinrrNt cyRm tRyt;.aydapd0leyhgodahh0dirl #ii ai nvntoviib "
nuo WrlnGe"d tbs<>t e>sGhinlvo: s>eiAdbiy"hl eleov:rhfmsd0troae seeae0s6>ycssfc#a e0 cpe ctod eo2rdga>Rre=cirhsy0sdIs"np en#"leIsaeo &ut semal;AoibrCe.c#oeitc grNe foi"lnsodeo.ynadpeinlieh
Please enable JavaScript to view this content.
Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.
|
